US Stock MarketDetailed Quotes

NAUT Nautilus Biotechnology

Watchlist
  • 2.840
  • +0.020+0.71%
Close Oct 15 16:00 ET
  • 2.840
  • 0.0000.00%
Post 16:02 ET
356.17MMarket Cap-5163P/E (TTM)

Nautilus Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.08%-15.46M
-29.88%-16.27M
-12.89%-51.71M
-33.95%-13.9M
-22.72%-11.74M
-0.15%-13.55M
-1.53%-12.52M
-16.73%-45.81M
1.35%-10.38M
32.53%-9.57M
Net income from continuing operations
-13.93%-18.01M
-25.16%-18.73M
-9.93%-63.68M
-26.96%-17.02M
-12.91%-15.88M
-7.62%-15.81M
5.06%-14.97M
-15.12%-57.92M
19.65%-13.41M
3.04%-14.06M
Depreciation and amortization
9.31%1.6M
35.87%1.59M
67.01%5.71M
72.64%1.59M
72.44%1.48M
76.24%1.46M
45.29%1.17M
20.20%3.42M
5.98%921K
17.17%860K
Change In working capital
-4.11%-1.62M
-61.78%-1.49M
-308.50%-3.22M
-434.88%-920K
-81.37%179K
24.53%-1.56M
-289.51%-921K
-3,481.82%-788K
-106.51%-172K
136.51%961K
-Change in prepaid assets
186.86%238K
39.77%-309K
-208.60%-821K
-88.97%57K
-112.26%-91K
74.08%-274K
-192.60%-513K
127.49%756K
-53.42%517K
121.03%742K
-Change in payables and accrued expense
-93.55%-840K
-247.46%-174K
632.89%810K
119.14%31K
64.91%1.1M
23.59%-434K
237.21%118K
-104.32%-152K
-114.78%-162K
-48.33%664K
-Change in other current liabilities
-20.02%-1.02M
-91.44%-1.01M
-130.46%-3.21M
-91.27%-1.01M
-85.39%-825K
-93.84%-849K
-3,022.22%-526K
-76.65%-1.39M
-221.15%-527K
-14.69%-445K
Cash from discontinued investing activities
Operating cash flow
-14.08%-15.46M
-29.88%-16.27M
-12.89%-51.71M
-33.95%-13.9M
-22.72%-11.74M
-0.15%-13.55M
-1.53%-12.52M
-16.73%-45.81M
1.35%-10.38M
32.53%-9.57M
Investing cash flow
Cash flow from continuing investing activities
733.88%14.29M
265.64%22.35M
-69.91%-43.74M
35.90%-41.06M
209.48%13.08M
-106.43%-2.26M
-188.89%-13.5M
81.48%-25.74M
-1,156.32%-64.06M
85.78%-11.94M
Net PPE purchase and sale
-10.58%-512K
6.50%-647K
-5.08%-2.44M
-80.35%-413K
9.24%-874K
28.88%-463K
-43.87%-692K
-2.42%-2.32M
76.77%-229K
-256.67%-963K
Net investment purchase and sale
926.23%14.81M
279.65%23M
-76.35%-41.29M
36.32%-40.65M
227.04%13.95M
-105.02%-1.79M
-181.74%-12.8M
82.87%-23.42M
-1,005.33%-63.83M
86.88%-10.98M
Cash from discontinued investing activities
Investing cash flow
733.88%14.29M
265.64%22.35M
-69.91%-43.74M
35.90%-41.06M
209.48%13.08M
-106.43%-2.26M
-188.89%-13.5M
81.48%-25.74M
-1,156.32%-64.06M
85.78%-11.94M
Financing cash flow
Cash flow from continuing financing activities
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
-99.83%562K
114.29%135K
681.82%86K
Proceeds from stock option exercised by employees
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
236.53%562K
114.29%135K
48.28%86K
Cash from discontinued financing activities
Financing cash flow
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
-99.83%562K
114.29%135K
681.82%86K
Net cash flow
Beginning cash position
-70.12%26.73M
-82.34%20.4M
-38.07%115.48M
-60.42%75.11M
-65.08%73.75M
-52.78%89.46M
-38.07%115.48M
400.98%186.46M
-0.57%189.77M
-26.92%211.2M
Current changes in cash
94.63%-844K
124.34%6.33M
-33.94%-95.08M
26.37%-54.71M
106.32%1.35M
-172.27%-15.71M
-966.40%-26.02M
-147.56%-70.98M
-1,591.64%-74.3M
78.17%-21.42M
End cash Position
-64.90%25.89M
-70.12%26.73M
-82.34%20.4M
-82.34%20.4M
-60.42%75.11M
-65.08%73.75M
-52.78%89.46M
-38.07%115.48M
-38.07%115.48M
-0.57%189.77M
Free cash flow
-13.97%-15.97M
-27.97%-16.91M
-12.51%-54.15M
-34.95%-14.31M
-19.79%-12.61M
1.18%-14.01M
-3.12%-13.22M
-15.95%-48.13M
7.81%-10.61M
27.13%-10.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.08%-15.46M-29.88%-16.27M-12.89%-51.71M-33.95%-13.9M-22.72%-11.74M-0.15%-13.55M-1.53%-12.52M-16.73%-45.81M1.35%-10.38M32.53%-9.57M
Net income from continuing operations -13.93%-18.01M-25.16%-18.73M-9.93%-63.68M-26.96%-17.02M-12.91%-15.88M-7.62%-15.81M5.06%-14.97M-15.12%-57.92M19.65%-13.41M3.04%-14.06M
Depreciation and amortization 9.31%1.6M35.87%1.59M67.01%5.71M72.64%1.59M72.44%1.48M76.24%1.46M45.29%1.17M20.20%3.42M5.98%921K17.17%860K
Change In working capital -4.11%-1.62M-61.78%-1.49M-308.50%-3.22M-434.88%-920K-81.37%179K24.53%-1.56M-289.51%-921K-3,481.82%-788K-106.51%-172K136.51%961K
-Change in prepaid assets 186.86%238K39.77%-309K-208.60%-821K-88.97%57K-112.26%-91K74.08%-274K-192.60%-513K127.49%756K-53.42%517K121.03%742K
-Change in payables and accrued expense -93.55%-840K-247.46%-174K632.89%810K119.14%31K64.91%1.1M23.59%-434K237.21%118K-104.32%-152K-114.78%-162K-48.33%664K
-Change in other current liabilities -20.02%-1.02M-91.44%-1.01M-130.46%-3.21M-91.27%-1.01M-85.39%-825K-93.84%-849K-3,022.22%-526K-76.65%-1.39M-221.15%-527K-14.69%-445K
Cash from discontinued investing activities
Operating cash flow -14.08%-15.46M-29.88%-16.27M-12.89%-51.71M-33.95%-13.9M-22.72%-11.74M-0.15%-13.55M-1.53%-12.52M-16.73%-45.81M1.35%-10.38M32.53%-9.57M
Investing cash flow
Cash flow from continuing investing activities 733.88%14.29M265.64%22.35M-69.91%-43.74M35.90%-41.06M209.48%13.08M-106.43%-2.26M-188.89%-13.5M81.48%-25.74M-1,156.32%-64.06M85.78%-11.94M
Net PPE purchase and sale -10.58%-512K6.50%-647K-5.08%-2.44M-80.35%-413K9.24%-874K28.88%-463K-43.87%-692K-2.42%-2.32M76.77%-229K-256.67%-963K
Net investment purchase and sale 926.23%14.81M279.65%23M-76.35%-41.29M36.32%-40.65M227.04%13.95M-105.02%-1.79M-181.74%-12.8M82.87%-23.42M-1,005.33%-63.83M86.88%-10.98M
Cash from discontinued investing activities
Investing cash flow 733.88%14.29M265.64%22.35M-69.91%-43.74M35.90%-41.06M209.48%13.08M-106.43%-2.26M-188.89%-13.5M81.48%-25.74M-1,156.32%-64.06M85.78%-11.94M
Financing cash flow
Cash flow from continuing financing activities 225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K-99.83%562K114.29%135K681.82%86K
Proceeds from stock option exercised by employees 225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K236.53%562K114.29%135K48.28%86K
Cash from discontinued financing activities
Financing cash flow 225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K-99.83%562K114.29%135K681.82%86K
Net cash flow
Beginning cash position -70.12%26.73M-82.34%20.4M-38.07%115.48M-60.42%75.11M-65.08%73.75M-52.78%89.46M-38.07%115.48M400.98%186.46M-0.57%189.77M-26.92%211.2M
Current changes in cash 94.63%-844K124.34%6.33M-33.94%-95.08M26.37%-54.71M106.32%1.35M-172.27%-15.71M-966.40%-26.02M-147.56%-70.98M-1,591.64%-74.3M78.17%-21.42M
End cash Position -64.90%25.89M-70.12%26.73M-82.34%20.4M-82.34%20.4M-60.42%75.11M-65.08%73.75M-52.78%89.46M-38.07%115.48M-38.07%115.48M-0.57%189.77M
Free cash flow -13.97%-15.97M-27.97%-16.91M-12.51%-54.15M-34.95%-14.31M-19.79%-12.61M1.18%-14.01M-3.12%-13.22M-15.95%-48.13M7.81%-10.61M27.13%-10.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data